Electrophysiology Mapping and Ablation Devices | Market Insights | Japan | 2022
Although the COVID-19 global pandemic has negatively impacted the Japanese EP mapping and ablation device market, the market is anticipated to recover over the near term, and subsequently resume moderate growth over the remainder of the forecast period, supported by increasing AF ablation procedure volumes and the emergence and adoption of novel technology, including pulsed field ablation and hybrid AF ablation systems. Market recovery is expected to occur over 2021, with market growth returning to prepandemic levels by 2023.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in Japan across an 11-year period.
Related Medtech Insights Reports
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
